Journal
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY
Volume 10, Issue 1, Pages 72-78Publisher
ELSEVIER
DOI: 10.1016/j.pdpdt.2012.06.001
Keywords
Ionizing radiation; Photodynamic therapy; Mitoxantrone; MCF-7 breast cancer
Categories
Funding
- Mashhad University of Medical Sciences, Mashhad, Iran
Ask authors/readers for more resources
This study evaluated the effects of mitoxantrone (MX) as a sensitizer following combined treatment with ionizing radiation and photodynamic therapy in the MCF-7 human breast cancer cell line. Cells were incubated with MX at different concentrations for 90 min and exposed to different fluence rates of non-coherent light and different dose rates of ionizing X-ray radiation in independent treatment groups. Additionally, the combined effects of chemotherapy, phototherapy, and radiotherapy were evaluated. The percent cell survival was investigated using the MIT assay. MX acted as both a photosensitizer and radiosensitizer. Furthermore, the use of 1 mu M MX in combination with PDT at 10 J/Cm-2 and 4 Gy of X-ray radiation strongly resulted in the death of cancer cells and reduced the percentage of viable cancer cells to 2.4 +/- 1.15. Our data demonstrated that the adverse effects of MX in combination with radiotherapy were partially abated, without a reduction in the efficacy of treatment. This new therapeutic avenue for breast cancer therapy merits further investigation using in vivo models for application in humans. (C) 2012 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available